Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MORRIS PLAINS, N.J., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today reported financial results for the fourth quarter and fiscal year ended June 30, 2015. The Company also...
-
MORRIS PLAINS, N.J., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced the appointment of Arthur S. Kirsch, 63, to its Board of Directors. Mr. Kirsch has over 30 years...
-
MORRIS PLAINS, N.J., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced the issuance of U.S. Patent No. 9,107,960 for a new patent family "Antibody-SN-38...
-
MORRIS PLAINS, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Thursday, August 20, 2015 at 10:00...
-
MORRIS PLAINS, N.J., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has...
-
CHICAGO, June 2, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced an interim analysis of a mid-stage clinical study showed that its first-in-class antibody-drug conjugate...
-
CHICAGO, June 2, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that sacituzumab govitecan, the Company's lead investigational antibody-drug conjugate (ADC), demonstrated...
-
CHICAGO, June 1, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that a majority of patients with heavily-pretreated, metastatic gastrointestinal cancers responded to...
-
CHICAGO, June 1, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that among 49 patients with metastatic triple-negative breast cancer (TNBC) evaluated for response to...
-
MORRIS PLAINS, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that the Company will present at Jefferies 2015 Global Healthcare Conference at 11:00 a.m....